norharman has been researched along with Atherosclerotic Parkinsonism in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Faraji, A; Haghdoost-Yazdi, H; Hosseini, SS; Jahanihashemi, H; Nahid, D | 1 |
| Beach, JW; Collins, MA; Gearhart, DA; Hwang, YI; Neafsey, EJ; Schwarz, J; Storch, A | 1 |
| Akaike, A; Gonda, T; Kawamura, T; Kimura, K; Kobayashi, Y; Matsubara, K; Ohtaki, K; Sawada, H; Uezono, T | 1 |
| Ohta, S; Yamakawa, T | 1 |
4 other study(ies) available for norharman and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Long term exposure to norharman exacerbates 6-hydroxydopamine-induced parkinsonism: possible involvement of L-type Ca2+ channels.
Topics: Analysis of Variance; Animals; Behavior, Animal; Brain; Calcium Channel Blockers; Calcium Channels, L-Type; Carbolines; Harmine; Male; Neurons; Nifedipine; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Wistar | 2010 |
Dopamine transporter-mediated cytotoxicity of beta-carbolinium derivatives related to Parkinson's disease: relationship to transporter-dependent uptake.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Carbolines; Cell Line; Cell Survival; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Harmaline; Harmine; Humans; Inhibitory Concentration 50; Kidney; Membrane Glycoproteins; Membrane Transport Modulators; Membrane Transport Proteins; Methylation; Nerve Tissue Proteins; Parkinson Disease, Secondary; Piperazines | 2004 |
Endogenously occurring beta-carboline induces parkinsonism in nonprimate animals: a possible causative protoxin in idiopathic Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Brain; Carbolines; Cells, Cultured; Dopamine; Embryo, Mammalian; Harmine; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Mesencephalon; Mice; Mice, Inbred C57BL; Neurons; Neurotoxins; Norepinephrine; Organ Specificity; Parkinson Disease, Secondary; Rats; Serotonin; Tyrosine 3-Monooxygenase | 1998 |
Biosynthesis of a parkinsonism-preventing substance, 1-methyl-1,2,3,4-tetrahydroisoquinoline, is inhibited by parkinsonism-inducing compounds in rat brain mitochondrial fraction.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Antipsychotic Agents; Biogenic Amines; Carbolines; Haloperidol; Harmine; Isoquinolines; Male; Mitochondria; Neurotoxins; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Tetrahydroisoquinolines | 1999 |